Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Oxford Immunotec logo

Oxford Immunotec

Recent Finacing

Equity

Recent Raise

$28M

Oxford Immunotec develops and operates laboratory-based T cell diagnostic tests, including the T‑SPOT.TB assay for detecting Mycobacterium tuberculosis–specific T cells, sells kits, and runs US and UK labs.

Founded 2002
Oxfordshire, United Kingdom
251-500
Publicly Traded
oxfordimmunotec.com

Highlights

Focus Areas

Biotechnology
Health Care
Health Diagnostics

Recent Investors

The Dow Chemical Company logo
NTEC logo
Draper Esprit logo
Spark Ventures logo
New Leaf Venture Partners logo
Kaiser Permanente Ventures logo
University of Oxford logo
Wellington Management logo
Clarus logo
Imperial Innovations logo
Invesco Perpetual logo
Oxford University logo

Financials

$54M

Total Raised

2

Funding rounds

14

Investors